Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 134241, "name": "Jagsonpal Pharma", "stock_name": "Jagsonpal Pharma", "full_name": "Jagsonpal Pharmaceuticals Ltd", "name_url": "stocks-analysis/jagsonpal-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "204.50", "chg": 3.45, "chgp": "1.72%", "dir": 1, "prev_price": "201.05", "mcapval": "1,327.00 Cr", "mcap": "Micro Cap", "scripcode": 507789, "symbol": "JAGSNPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE048B01035", "curr_date": "Jun 10, 03:30 PM", "curr_time": "22:36 PM", "last_traded_at": "Jun 10, 03:30 PM IST", "bse_nse_vol": "59.11 k", "exc_status": "Active", "traded_date": "Jun 10, 2026", "traded_date_str": "2026 06 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Jagsonpal Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-strong-sell-4036722", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JagsonpalPharma_mojoScore_4036722.png", "date": "2026-06-06 10:10:48", "description": "Jagsonpal Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Jagsonpal Pharmaceuticals Declines 1.39% Amid Strong Sell Downgrade and Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-declines-139-amid-strong-sell-downgrade-and-mixed-technical-signals-4024698", "imagepath": "", "date": "2026-05-31 16:01:28", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock opens at Rs.209.30, closes lower at Rs.205.20 (-1.96%) amid downgrade news</p>\n <p><strong>26 May:</strong> Downgrade to Strong Sell announced; technical indicators shift to mildly bearish</p>\n <p><strong>27 May:</strong> Stock recovers slightly to Rs.209.20 (+0.92%) on moderate volume</p>\n <p><strong>29 May:</strong> Week closes at Rs.206.40 (-1.34%), underperforming Sensex</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.209.30</div></div>\n <div class=\"sta..." }, { "title": "Jagsonpal Pharmaceuticals Downgraded to Strong Sell Amid Technical and Financial Weakness", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-downgraded-to-strong-sell-amid-technical-and-financial-weakness-4012889", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_mojoScore_4012889.png", "date": "2026-05-26 08:18:17", "description": "Jagsonpal Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. The downgrade reflects growing concerns over the company’s recent quarterly performance, deteriorating technical signals, and expensive valuation relative to its peers, despite its net-debt-free status." }, { "title": "Jagsonpal Pharmaceuticals Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-signals-4012362", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_4012362.png", "date": "2026-05-26 08:00:30", "description": "Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. Despite this, the stock continues to show pockets of strength in certain weekly indicators, reflecting a complex interplay of market forces and investor sentiment." }, { "title": "Jagsonpal Pharmaceuticals Gains 1.36%: Technical Momentum Shift Amid Mixed Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-gains-136-technical-momentum-shift-amid-mixed-fundamentals-4009563", "imagepath": "", "date": "2026-05-24 17:00:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> Stock opens at Rs.200.15, down 3.08% amid broader market weakness</p>\n <p><strong>19 May:</strong> Mojo Grade upgraded to Sell from Strong Sell on technical improvements</p>\n <p><strong>21 May:</strong> Sharp price jump to Rs.211.70 (+5.64%) signalling renewed buying interest</p>\n <p><strong>22 May:</strong> Week closes at Rs.209.30, down slightly from prior day but up 1.36% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.200.15</div></div>\n <div cla..." }, { "title": "Jagsonpal Pharmaceuticals Ltd Shows Signs of Technical Momentum Shift Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-shows-signs-of-technical-momentum-shift-amid-mixed-indicators-4004139", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_4004139.png", "date": "2026-05-22 08:00:11", "description": "Jagsonpal Pharmaceuticals Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a blend of technical indicators that present a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Jagsonpal Pharmaceuticals Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3998252", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_mojoScore_3998252.png", "date": "2026-05-19 08:15:30", "description": "Jagsonpal Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook amid ongoing financial headwinds. While the company’s quarterly results remain under pressure, improvements in technical indicators and a stabilising price trend have prompted a reassessment of its market stance." }, { "title": "Jagsonpal Pharmaceuticals Falls 5.23%: Mixed Technicals and Downgrade Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-falls-523-mixed-technicals-and-downgrade-shape-weekly-trend-3995643", "imagepath": "", "date": "2026-05-17 16:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Stock opens at ₹210.20, down 3.53% amid broad market weakness</p>\n <p><strong>12 May:</strong> Technical momentum shifts to mildly bearish; stock closes at ₹212.65 (+1.17%)</p>\n <p><strong>13 May:</strong> Downgrade to Strong Sell rating announced following weak financials</p>\n <p><strong>14 May:</strong> Technical trend shifts to sideways; stock closes at ₹210.05 (-1.22%)</p>\n <p><strong>15 May:</strong> Week closes at ₹206.50 (-0.55%) amid subdued volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">..." }, { "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-3990280", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3990280.png", "date": "2026-05-14 08:00:13", "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day decline of 1.22%, the stock’s longer-term performance continues to outpace the Sensex, though technical indicators suggest caution for investors navigating this micro-cap pharmaceutical player." } ], "total": 262, "sid": "134241", "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS", "datetime": "04-Jun-2026", "details": "Allotment of 296320 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan 2022.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Closure of Buy Back", "datetime": "02-Jun-2026", "details": "Extinguishment of 1600000 Equity Shares of Jagsonpal Pharmaceuticals Limited.", "source": "BSE" }, { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "28-May-2026", "details": "Please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>125%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25", "dt": "2025-01-08", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: Stock opens at ₹210.20, down 3.53% amid broad market weakness

12 May: Technical momentum shifts to mildly bearish; stock closes at ₹212.65 (+1.17%)

13 May: Downgrade to Strong Sell rating announced following weak financials

14 May: Technical trend shifts to sideways; stock closes at ₹210.05 (-1.22%)

15 May: Week closes at ₹206.50 (-0.55%) amid subdued volume

...

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-05-14 08:00:13

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day decline of 1.22%, the stock’s longer-term performance continues to outpace the Sensex, though technical indicators suggest caution for investors navigating this micro-cap pharmaceutical player.

Read full news article